Mitzie sells AZN 74.1: FDA panel recommends more clinical data on AstraZeneca drug, (NYSE: AZN)
An advisory panel to the U.S. Food and Drug Administration recommended on Wednesday that AstraZeneca Plc be required to submit further clinical data before its experimental ovarian cancer drug is approved.The panel voted 11-2 that the company should ... ...
42 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home